Yes! I decided to take a closer look(while we await further clarification) at the 2 events that the "Digital Biopsy Tool" will be showcased as I think it is easy to overlook the significance of these events. The first of which, EANS 2017, concluded yesterday in Venice. With close to 2000 people tipped to attend this event, many of whom are Europe's leading neurosurgeons aswel as numerous world-wide industry-related experts, I believe it is the perfect platform to unveil our patented tech.
The CNS 2017 event commences in 2 days time, and by the looks of it Zeiss have sponsored a 1.5hr 'lunch theater' on the 9th where they will be showcasing the Zeiss 'QEVO' among other things. The following link has a more comprehensive overview of what they will be covering throughout the event:
https://www.zeiss.com/meditec/us/c/cns.html
NOTE: '
We are excited to bring the all-new Robotic Visualization System KINEVO® 900 from ZEISS, to CNS 2017 in Boston, MA. Visit us at booth 539 October 9-11 to experience this newest technology first-hand...'
I also noted towards the bottom of the web-page '
...the discussion may include information on products and features that are a work in progress, may require FDA510(k) clearance and are subject to change...' (this warning can also be seen in the frist frame of the 17 second QEVO promotional video). The Zeiss 'QEVO'(micro-inspection tool) which plugs into the Kinevo 900, will be presented by Professor of Neurosurgery, Peter Nakaji. Nakaji has written several research articles and publications on endoscopic approaches to the parasellar region located in the brain, with cited help from another neurosurgeon, Evgenii Belykh. Belykh presented at the EANS 2017 event on the 3rd of October(which is coincidentally the same date highlighted as the date of unveiling the 'Digital Biopsy Tool') in regards to '
Handheld confocal laser endomicroscopy for intraoperative optical biopsy of brain tumors'.
I can't say for certain but I personally think the 'QEVO', highlighted in a earlier thread by
@gmutton, may be the device that utilises Optiscans tech. Either way being able to showcase our tech at such prestigious events with so many industry-leading experts is a great stepping stone in our path to comercialisation.
Please note that I am just speculating by joining the dots and this is
ALL IMO PLS DYOR
GC
(20min delay)
